P833: MARCH5 AS A POTENTIAL THERAPEUTIC TARGET IN MULTIPLE MYELOMA

• Hamed Bashiri,
• Ahad Khalilnezhad,
• Haruhito Totani,
• Chung Tae-Hoon,
• Wee Joo Chng,
• Joe Yeong,
• Toshio Suda

Affiliations

Hamed Bashiri

1 Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore

Ahad Khalilnezhad

3 International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan

Haruhito Totani

2 Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Chung Tae-Hoon

2 Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Wee Joo Chng

2 Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Joe Yeong

1 Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore

Toshio Suda

2 Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore